KEY POINTS Despite serious disruptions to tuberculosis (TB) programs during the COVID-19 pandemic, including in Canada,[1][1] the past few years have also seen global advances in TB treatment. Novel drugs and regimens have been developed to support faster, safer, more effective treatment for drug-